XML 27 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION CF (Details) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash Flow [Line Items]    
Net cash provided by (used in) operating activities $ 134,898 $ 116,993
Capital expenditures (113,405) (149,262)
Proceeds from asset dispositions 96,376 12,040
Investment in unconsolidated affiliate 7,153 0
Net cash used in investing activities (24,182) (137,222)
Proceeds from borrowings 0 88,493
Repayment of debt (24,300) (32,518)
Dividends paid (14,297) (10,833)
Increases (decreases) in cash related to intercompany advances and debt 0 0
Partial Prepayment Of Put Call Obligation (33) (31)
Acquisition of noncontrolling interest 0 (262)
Issuance of Common Stock 7,869 1,629
Tax benefit related to stock-based compensation 433 109
Net cash provided by (used in) financing activities (30,328) 46,587
Effect of exchange rate changes on cash and cash equivalents 6,411 (2,440)
Net increase (decrease) in cash and cash equivalents 86,799 23,918
Cash and cash equivalents at beginning of period 261,550 116,361
Cash and cash equivalents at end of period 348,349 140,279
Parent Company [Member]
   
Cash Flow [Line Items]    
Net cash provided by (used in) operating activities (20,075) (18,520)
Capital expenditures (8,353) (418)
Proceeds from asset dispositions 0 0
Investment in unconsolidated affiliate 7,153  
Net cash used in investing activities (15,506) (418)
Proceeds from borrowings   87,800
Repayment of debt (24,300) (30,000)
Dividends paid (2,742) 40,564
Increases (decreases) in cash related to intercompany advances and debt 112,427 (22,056)
Partial Prepayment Of Put Call Obligation (33) (31)
Acquisition of noncontrolling interest   0
Issuance of Common Stock 7,869 1,629
Tax benefit related to stock-based compensation 433 109
Net cash provided by (used in) financing activities 93,654 78,015
Effect of exchange rate changes on cash and cash equivalents 0 0
Net increase (decrease) in cash and cash equivalents 58,073 59,077
Cash and cash equivalents at beginning of period 76,609 24,075
Cash and cash equivalents at end of period 134,682 83,152
Guarantor Subsidiaries [Member]
   
Cash Flow [Line Items]    
Net cash provided by (used in) operating activities 62,030 60,830
Capital expenditures (46,389) (78,620)
Proceeds from asset dispositions 35,185 8,129
Investment in unconsolidated affiliate 0  
Net cash used in investing activities (11,204) (70,491)
Proceeds from borrowings   0
Repayment of debt 0 0
Dividends paid (9,755) (24,927)
Increases (decreases) in cash related to intercompany advances and debt (40,697) 32,153
Partial Prepayment Of Put Call Obligation 0 0
Acquisition of noncontrolling interest   (262)
Issuance of Common Stock 0 0
Tax benefit related to stock-based compensation 0 0
Net cash provided by (used in) financing activities (50,452) 6,964
Effect of exchange rate changes on cash and cash equivalents 0 0
Net increase (decrease) in cash and cash equivalents 374 (2,697)
Cash and cash equivalents at beginning of period 3,155 5,233
Cash and cash equivalents at end of period 3,529 2,536
Non-Guarantor Subsidiaries [Member]
   
Cash Flow [Line Items]    
Net cash provided by (used in) operating activities 92,943 74,683
Capital expenditures (83,252) (70,224)
Proceeds from asset dispositions 85,780 3,911
Investment in unconsolidated affiliate 0  
Net cash used in investing activities 2,528 (66,313)
Proceeds from borrowings   693
Repayment of debt 0 (2,518)
Dividends paid (1,800) (26,470)
Increases (decreases) in cash related to intercompany advances and debt (71,730) (10,097)
Partial Prepayment Of Put Call Obligation 0 0
Acquisition of noncontrolling interest   0
Issuance of Common Stock 0 0
Tax benefit related to stock-based compensation 0 0
Net cash provided by (used in) financing activities (73,530) (38,392)
Effect of exchange rate changes on cash and cash equivalents 6,411 (2,440)
Net increase (decrease) in cash and cash equivalents 28,352 (32,462)
Cash and cash equivalents at beginning of period 181,786 87,053
Cash and cash equivalents at end of period 210,138 54,591
Consolidations, Eliminations [Member]
   
Cash Flow [Line Items]    
Net cash provided by (used in) operating activities 0 0
Capital expenditures 24,589 0
Proceeds from asset dispositions (24,589) 0
Investment in unconsolidated affiliate 0  
Net cash used in investing activities 0 0
Proceeds from borrowings   0
Repayment of debt 0 0
Dividends paid 0 0
Increases (decreases) in cash related to intercompany advances and debt 0 0
Partial Prepayment Of Put Call Obligation 0 0
Acquisition of noncontrolling interest   0
Issuance of Common Stock 0 0
Tax benefit related to stock-based compensation 0 0
Net cash provided by (used in) financing activities 0 0
Effect of exchange rate changes on cash and cash equivalents 0 0
Net increase (decrease) in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period $ 0 $ 0